Stifel Financial Corp Sells 13,598 Shares of Colgate-Palmolive (NYSE:CL)

Stifel Financial Corp cut its holdings in Colgate-Palmolive (NYSE:CL - Free Report) by 0.3% in the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 5,016,212 shares of the company's stock after selling 13,598 shares during the quarter. Stifel Financial Corp owned about 0.61% of Colgate-Palmolive worth $520,735,000 at the end of the most recent quarter.

Several other hedge funds also recently modified their holdings of the business. E Fund Management Hong Kong Co. Ltd. bought a new stake in Colgate-Palmolive during the second quarter worth approximately $25,000. Continuum Advisory LLC boosted its holdings in shares of Colgate-Palmolive by 46.5% during the 2nd quarter. Continuum Advisory LLC now owns 394 shares of the company's stock worth $38,000 after buying an additional 125 shares during the period. Reston Wealth Management LLC acquired a new position in Colgate-Palmolive in the 3rd quarter valued at $42,000. Capital Performance Advisors LLP bought a new position in Colgate-Palmolive in the 3rd quarter worth $53,000. Finally, Prospera Private Wealth LLC acquired a new position in Colgate-Palmolive during the 3rd quarter worth $64,000. Institutional investors and hedge funds own 80.41% of the company's stock.

Analysts Set New Price Targets

A number of research firms have recently commented on CL. Stifel Nicolaus lowered Colgate-Palmolive from a "buy" rating to a "hold" rating and dropped their price objective for the stock from $105.00 to $101.00 in a research note on Monday, October 28th. UBS Group lifted their price target on Colgate-Palmolive from $119.00 to $122.00 and gave the stock a "buy" rating in a research report on Wednesday, September 4th. Piper Sandler began coverage on Colgate-Palmolive in a research report on Tuesday, September 24th. They issued an "overweight" rating and a $121.00 price objective for the company. Deutsche Bank Aktiengesellschaft lowered shares of Colgate-Palmolive from a "buy" rating to a "hold" rating and boosted their target price for the stock from $107.00 to $109.00 in a research report on Monday, September 9th. Finally, StockNews.com upgraded shares of Colgate-Palmolive from a "hold" rating to a "buy" rating in a research report on Monday, November 25th. One investment analyst has rated the stock with a sell rating, nine have assigned a hold rating and thirteen have given a buy rating to the stock. According to data from MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and an average price target of $105.11.

Colgate-Palmolive Price Performance

CL stock traded up $0.32 during trading on Thursday, hitting $95.13. 4,407,090 shares of the stock traded hands, compared to its average volume of 4,384,156. The stock has a market cap of $77.72 billion, a price-to-earnings ratio of 27.17, a P/E/G ratio of 3.38 and a beta of 0.43. Colgate-Palmolive has a one year low of $75.50 and a one year high of $109.30. The company has a current ratio of 1.04, a quick ratio of 0.68 and a debt-to-equity ratio of 9.46. The company has a 50 day simple moving average of $96.89 and a 200 day simple moving average of $98.63.

Colgate-Palmolive Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, November 15th. Stockholders of record on Friday, October 18th were issued a $0.50 dividend. This represents a $2.00 annualized dividend and a dividend yield of 2.10%. The ex-dividend date was Friday, October 18th. Colgate-Palmolive's payout ratio is currently 57.31%.

Insider Buying and Selling

In other news, CFO Stanley J. Sutula III sold 45,410 shares of the stock in a transaction that occurred on Tuesday, November 5th. The shares were sold at an average price of $94.11, for a total transaction of $4,273,535.10. Following the sale, the chief financial officer now directly owns 36,726 shares of the company's stock, valued at $3,456,283.86. This represents a 55.29 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. 0.34% of the stock is owned by corporate insiders.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.